Ophthalmology Doctors in Hayward, CA Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Patricia Sunae Yoon Ferrell, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1237 B St, Hayward, CA 94541 Phone: 510-886-3937    Fax: 510-886-6304

Lee T. Du, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 27400 Hesperian Blvd, Hayward, CA 94545 Phone: 510-784-4000

Dr. Tonya Thurber Alberelli, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1237 B St, Hayward, CA 94541 Phone: 510-886-3937    Fax: 510-886-6304

Arthur A. Ollivierre, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 27400 Hesperian Blvd, Hayward, CA 94545 Phone: 510-784-4000

Shirin Barez, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1237 B St, Hayward, CA 94541 Phone: 510-886-3937    Fax: 510-886-6304

Mr. Mark Richard Mandel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1237 B St, Hayward, CA 94541 Phone: 510-886-3937    Fax: 510-886-6304

Dr. Robin K Kuriakose, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1237 B St, Hayward, CA 94541 Phone: 510-886-5497    Fax: 510-886-4465

News Archive

Smoking increases likelihood that pancreatic ductal adenocarcinoma will become metastatic

Smoking has once again been implicated in the development of advanced cancer. Exposure to nicotine by way of cigarette smoking may increase the likelihood that pancreatic ductal adenocarcinoma will become metastatic, according to researchers from the Kimmel Cancer Center at Jefferson.

Some researchers question conclusion in Nature study that stem cells can be created without destroying embryos

Some human embryonic stem cell researchers recently have questioned whether methods used in a study published in the Aug. 24 edition of the journal Nature were sufficient to conclude that human embryonic stem cells could be created without destroying the embryo, the Wall Street Journal reports (Hamilton/Regalado, Wall Street Journal, 9/5).

Searching for the right pharmaceutical agent: survival as the indicator

Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.

Biologic therapies are changing the way dermatologists treat psoriasis

Recently approved and investigational biologic therapies are changing the way dermatologists treat psoriasis, a chronic disease that physically and emotionally challenges 4.5 million Americans. As more research is conducted into the effectiveness of these biologics, they are showing great promise for improving the health and well-being of patients with psoriasis.

Read more Medical News

› Verified 1 days ago